NIH-funded research R01 grant

Investigating how mast cell stabilization affects heart inflammation and glucose use in aging hearts after a heart attack

Official title: Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium

Funded at Cedars-Sinai Medical Center · NIH-11062399 · Data updated 2026-11-12

This study is looking at how keeping certain cells in the heart stable might help reduce inflammation and improve how the heart uses sugar in older adults who have had a heart attack, using special imaging techniques to better understand heart health and metabolism.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$751,427
NIH project number5R01HL168635-03
Project IDNIH-11062399 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults who have experienced a heart attack and are not diabetic.

Less likely to help

Patients who are younger or do not have a history of heart attacks may not benefit from this research.

What this research studies

This research focuses on understanding how mast cell stabilization can influence inflammation and glucose utilization in the hearts of older adults who have experienced a heart attack. By using advanced imaging techniques like PET/MRI, the study aims to assess the effects of fat accumulation in heart tissue and its relationship with insulin resistance. The research will involve both animal models and human participants to explore the underlying mechanisms of heart failure and metabolic changes in aging hearts. Patients may undergo imaging and assessments to evaluate their heart health and metabolic function.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart health and metabolic function in older adults, potentially reducing the risk of heart failure.

How similar studies have gone: Previous research has shown promising results in understanding the role of inflammation and fat accumulation in heart disease, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Cokic, Ivan — Cedars-Sinai Medical Center
  • Study coordinator: Cokic, Ivan

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.